The Cyromazine market is projected to register a CAGR of 3.52% during the forecast period (2021- 2026). Cyromazine is an insect growth regulator (IGR) and is a cyclopropyl & an aminotriazine derivative of melamine. Cyromazine finds application in animal healthcare and agriculture. Cyromazine and other IGRs interfere with the life cycle of insects by acting […]
Cyromazine Market to Hit USD 428.64 Million by 2026
The Cyromazine market is projected to register a CAGR of 3.52% during the forecast period (2021- 2026).
Cyromazine is an insect growth regulator (IGR) and is a cyclopropyl & an aminotriazine derivative of melamine. Cyromazine finds application in animal healthcare and agriculture. Cyromazine and other IGRs interfere with the life cycle of insects by acting on the hormonal control of development. IGRs interfere with normal progress and growth of the insect, resulting in an insect’s mortality before it reaches adulthood.
A detailed report on Global Cyromazine Market Market providing a complete information on the current market situation and offering robust insights about the potential size, volume, and dynamics of the market during the forecast period, 2021-2027.
Top Key Players in Cyromazine Market market: Syngenta AG, ADAMA Agricultural Solutions Ltd., Elanco Animal Health Inc., Jurox Pty Limited., Arysta LifeScience Corporation, Lasa Supergenerics Limited, Orion AgriScience Limited, Topsen Biotech Co. Ltd., Shandong Luxi Animal Medicine Share Co., Ltd., Bayer AG, and Toronto Research Chemicals Inc.
Regional Analysis For Cyromazine Market Market:
Besides segmental breakdown, the report is highly structured into region wise study. The regional analysis comprehensively done by the researchers highlights key regions and their dominating countries accounting for substantial revenue share in the Cyromazine Market market. The study helps understanding how the market will fare in the respective region, while also mentioning the emerging regions growing with a significant CAGR. The following are the regions covered in this report.
Key Market Drivers:
Increasing demand for cyromazine in agriculture and animal healthcare is expected to augment the growth of the cyromazine market during the forecast period. For instance, in February 2021, RR Animal Health Care Ltd. developed Cyromazine Active Pharmaceutical Ingredient (API) for the poultry segment. With the development of Cyromazine 99.5%, RR Animal Health Care became the first company develop this molecule with complete backward integration using a Green Chemistry route without the use of solvents.
Key Takeaways:
The cyromazine market is expected to exhibit a CAGR of 3.52 % during the forecast period owing to the increasing need for pest control in livestock and agriculture, worldwide. For instance, in September 2019, Shandong Luxi Animal Medicine Share Co., Ltd. launched its animal nutrition product Cyromazine at the Qingdao World Expo City. According to the company, for control of fly larvae in cattle, pig, and poultry-operations, cyromazine is set to effectively control the reproduction of the larvae of flies in animal stables.
Among regions, North America and Asia Pacific are expected to witness robust growth in the cyromazine market, owing to the increasing demand for cyromazine in agriculture and animal healthcare, increasing demand for food and agricultural products, and rapid growth of the agrochemical industry. For instance, according to the India Brand Equity Foundation (IBEF), the Indian agrochemical industry was expected to reach US$ 6.3 billion by 2020, from US$ 4.4 billion in 2015, with 7.5% annually growth.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
The post Cyromazine market is expected to reach USD 428.64 million by 2026 appeared first on Gatorledger.
